Currently out of the existing stock ratings of Fedor Shabalin, 17 are a BUY (94.44%), 1 are a HOLD (5.56%).

Fedor Shabalin

Work Performance Price Targets & Ratings Chart

Analyst Fedor Shabalin, currently employed at B. RILEY, carries an average stock price target met ratio of 16.67% that have a potential upside of 18.17% achieved within 15 days.

Fedor Shabalin’s has documented 36 price targets and ratings displayed on 4 stocks. The coverage is on the Technology sector.

Most recent stock forecast was given on HSDT, Helius Medical Technologies at 22-Sep-2026.

Wall Street Analyst Fedor Shabalin

Analyst best performing recommendations are on HSDT (HELIUS MEDICAL TECHNOLOGIES).
The best stock recommendation documented was for HSDT (HELIUS MEDICAL TECHNOLOGIES) at 8/17/2026. The price target of $2.5 was fulfilled within 32 days with a profit of $0.84 (50.6%) receiving and performance score of 15.81.

Average potential price target upside

SQNS Sequans Communications SA HIVE HIVE Blockchain Technologies Ltd MSTR MicroStrategy HSDT Helius Medical Technologies

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 05-Jan-2018

$15

$12.29 (453.51%)

$75

7 days ago
(08-Oct-2026)

0/14 (0%)

$12.24 (443.48%)

Buy Since 16-Oct-2025

$5

$2.29 (84.50%)

$8

1 months 21 days ago
(24-Aug-2026)

0/4 (0%)

$2 (66.67%)

Buy Since 10-Dec-2025

$10

$7.29 (269.00%)

$18

4 months 13 days ago
(02-Jun-2026)

0/2 (0%)

$6.01 (150.63%)

Buy Since 10-Oct-2017

$75

$72.29 (2667.53%)

$250

3 years 2 months 7 days ago
(08-Aug-2023)

1/4 (25%)

$5.75 (8.30%)

702

Buy Since 18-Mar-2016

$75.75

$73.04 (2695.20%)

$200

3 years 2 months 8 days ago
(07-Aug-2023)

1/10 (10%)

$6 (8.60%)

411

Show more analysts

Please expand the browser size to see the chart

Which stock is Fedor Shabalin most bullish on?

Potential upside of $40.66 has been obtained for MSTR (MICROSTRATEGY)

Which stock is Fedor Shabalin most reserved on?

Potential downside of $1.61 has been obtained for HSDT (HELIUS MEDICAL TECHNOLOGIES)

What Year was the first public recommendation made by Fedor Shabalin?

On 2025
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?